PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP

被引：0

作者：

Castagnetti, F. ^{[1
]}

Gugliotta, G. ^{[1
]}

Breccia, M. ^{[2
]}

Specchia, G. ^{[3
]}

Binotto, G. ^{[4
]}

Abruzzese, E. ^{[5
]}

Iurlo, A. ^{[6
]}

Vigneri, P. ^{[7
]}

Cavazzini, F. ^{[8
]}

Intermesoli, T. ^{[9
]}

Ferrero, D. ^{[10
]}

Martino, B. ^{[11
]}

Leoni, P. ^{[12
]}

Bocchia, M. ^{[13
]}

Rege-Cambrin, G. ^{[14
]}

Gherlinzoni, F. ^{[15
]}

Bochicchio, M. T. ^{[1
]}

Soverini, S. ^{[1
]}

Alimena, G. ^{[2
]}

Pane, F. ^{[16
]}

Saglio, G. ^{[14
]}

Cavo, M. ^{[1
]}

Martinelli, G. ^{[1
]}

Baccarani, M. ^{[17
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Roma La Sapienza, Chair Hematol, I-00185 Rome, Italy

[3] Univ Bari, Chair Hematol, Bari, Italy

[4] Univ Padua, Chair Hematol, Padua, Italy

[5] S Eugenio Hosp, Hematol Unit, Rome, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore, Hematol Unit, Milan, Italy

[7] Univ Catania, Chair Hematol, Catania, Italy

[8] Univ Ferrara, Chair Hematol, I-44100 Ferrara, Italy

[9] Osped Riuniti Bergamo, Hematol Unit, I-24100 Bergamo, Italy

[10] Univ Turin, Chair Hematol, Turin, Italy

[11] Osped Riuniti Reggio Calabria, Hematol Unit, Reggio Di Calabria, Italy

[12] Torrette Univ Hosp, Chair Hematol, Ancona, Italy

[13] Univ Siena, Chair Hematol, I-53100 Siena, Italy

[14] S Luigi Gonzaga Univ Hosp, Chair Hematol, Orbassano, TO, Italy

[15] Ca Foncello Hosp, Hematol Unit, Treviso, Italy

[16] Univ Naples Federico II, Chair Hematol, Naples, Italy

[17] Univ Bologna, Dept Hematol & Oncol L&A Seragnoli, Bologna, Italy

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S810

引用

页码：324 / 324

页数：1

共 50 条

[1] Outcome of 472 Chronic Myeloid Leukemia Patients Treated with Frontline Nilotinib: A Gimema CML WP Analysis
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Iurlo, Alessandra
D'Adda, Mariella
Stagno, Fabio
Levato, Luciano
Martino, Bruno
Lunghi, Francesca
Tiribelli, Mario
Cambrin, Giovanna Rege
Abruzzese, Elisabetta
Rupoli, Serena
Gozzini, Antonella
Pregno, Patrizia
Salvucci, Marzia
Trabacchi, Elena
Caocci, Giovanni
Scortechini, Anna Rita
Luciano, Luigia
Tagariello, Giuseppe
Bonifacio, Massimiliano
Soverini, Simona
Foa, Robin
Martinelli, Giovanni
Cavo, Michele
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2018, 132
[2] CLINICAL SIGNIFICANCE OF EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE
Castagnetti, F.
Gugliotta, G.
Breccia, M.
Albano, F.
Abruzzese, E.
Levato, L.
Cavazzini, F.
Lurlo, A.
Stagno, F.
Ferrero, D.
Porretto, F.
Martino, B.
Rupoli, S.
Intermesoli, T.
Fava, C.
Pierri, I.
Palandri, F.
Venturi, C.
Soverini, S.
Luatti, S.
Alimena, G.
Pane, F.
Martinelli, G.
Saglio, G.
Cavo, M.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2013, 98 : 59 - 59
[3] VARIANT PHILADELPHIA TRANSLOCATION IN EARLY CHRONIC PHASE OF CHRONIC MYELOID LEUKEMIA: RESULTS OF IMATINIB MESYLATE THERAPY (A GIMEMA WP ON CML ANALYSIS)
Marzocchi, G.
Luatti, S.
Castagnetti, F.
Gamberini, C.
Baldazzi, C.
Stacchini, M.
Amabile, M.
Iacobucci, I.
Specchia, G.
Sessarego, M.
Giussani, U.
Zanatta, L.
Discepoli, G.
Montaldi, A.
Santoro, A.
Sebastio, L.
Biondi, A.
Bonaldi, L.
Cianciulli, A.
Cuneo, A.
Mancini, M.
Mecucci, C.
Palandri, F.
Rosti, G.
Baccarani, M.
Testoni, N.
HAEMATOLOGICA, 2008, 93 : S73 - S73
[4] The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Specchia, Giorgina
Abruzzese, Elisabetta
Levato, Luciano
Cavazzini, Francesco
Iurlo, Alessandra
Stagno, Fabio
Ferrero, Dario
Porretto, Ferdinando
Martino, Bruno
Rupoli, Serena
Intermesoli, Tamara
Fava, Carmen
Palandri, Francesca
Venturi, Claudia
Soverini, Simona
Testoni, Nicoletta
Alimena, Giuliana
Pane, Fabrizio
Saglio, Giuseppe
Martinelli, Giovanni
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2012, 120 (21)
[5] INFLUENCE OF ADDITIONAL CHROMOSOME ABNORMALITIES TO PH ON RESPONSE TO IMATINIB MESYLATE THERAPY IN EARLY CHRONIC PHASE IN CHRONIC MYELOID LEUKEMIA. (A GIMEMA WP ON CML ANALYSIS)
Luatti, S.
Marzocchi, G.
Castagnetti, F.
Gamberini, C.
Baldazzi, C.
Stacchini, M.
Poerio, A.
Zaccaria, A.
Zanatta, L.
Giugliano, E.
Santulli, B.
Grimoldi, M. G.
Gozzetti, A.
Dalsass, A.
Piovani, G.
Manna, M.
Modaferri, B.
Bernardi, F.
Bernasconi, P.
Kerim, S.
Abruzzese, E.
Palka, G.
Palandri, F.
Martinelli, G.
Rosti, G.
Baccarani, M.
Testoni, N.
HAEMATOLOGICA, 2008, 93 : S52 - S52
[6] VARIANT PH TRANSLOCATION IN EARLY CHRONIC PHASE OF CHRONIC MYELOID LEUKEMIA: CYTOGENETIC - MOLECULAR CHARACTERIZATION AND CORRELATION TO IMATINIB MESYLATE THERAPY (A GIMEMA WP ON CML ANALYSIS)
Marzocchi, G.
Luatti, S.
Castagnatti, F.
Baldazzi, C.
Stacchini, M.
Gamberini, C.
Amabile, M.
Soverini, S.
Colarossi, S.
Specchia, G.
Sessarego, M.
Giussani, U.
Zanatta, L.
Valori, L.
Discepoli, G.
Montaldi, A.
Santoro, A.
Sebastio, L.
Giudici, G.
Bonaldi, L.
Cianciulli, A.
Giacobbi, F.
Palandri, F.
Rosti, G.
Baccarani, M.
Testoni, N.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 333 - 333
[7] CLINICAL SIGNIFICANCE OF MR2 AT ONE YEAR AND BEYOND: A GIMEMA CML WP ANALYSIS ON 559 CML PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE
Castagnetti, F.
Gugliotta, G.
Breccia, M.
Stagno, F.
Iurlo, A.
Albano, F.
Abruzzese, E.
Martino, B.
Levato, L.
Intermesoli, T.
Pregno, P.
D'Adda, M.
Calistri, E.
Rupoli, S.
Cavazzini, F.
Ferrero, D.
Caocci, G.
Bocchia, M.
Tiribelli, M.
Montefusco, E.
Sora, F.
Bonifacio, M.
Elena, C.
Soverini, S.
Foa, R.
Cavo, M.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2019, 104 : 141 - 141
[8] Molecular response of paediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
Dhara, Atanu
Mukhopadhyay, S.
Das, S.
Mukhopadhyay, A.
PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 444 - 445
[9] Frontline Treatment With Imatinib Mesylate in Chronic Myeloid Leukemia Patients in Early Chronic Phase: a Very Long-Term Analysis by the GIMEMA CML Working Party
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Specchia, Giorgina
Intermesoli, Tamara
Capucci, Adele
Martino, Bruno
Tiribelli, Mario
Binotto, Gianni
Abruzzese, Elisabetta
Stagno, Fabio
Leoni, Pietro
Ferrero, Dario
Gherlinzoni, Filippo
Palandri, Francesca
Venturi, Claudia
Bochicchio, Maria Teresa
Soverini, Simona
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Cavo, Michele
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2013, 122 (21)
[10] DELETIONS OF THE DERIVATIVE CHROMOSOME 9 DO NOT INFLUENCE THE OUTCOME OF CHRONIC MYELOID LEUKEMIA IN EARLY CHRONIC PHASE TREATED WITH IMATINIB MESYLATE: A GIMEMA CML WP ANALYSIS OF 521 CONSECUTIVE PATIENTS
Castagnetti, F.
Testoni, N.
Luatti, S.
Marzocchi, G.
Gugliotta, G.
Palandri, F.
Amabile, M.
Soverini, S.
Mancini, M.
Kerim, S.
Giuliano, E.
Specchia, G.
Cuneo, A.
Abruzzese, E.
Martinelli, G.
Pane, F.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 125 - 125

← 1 2 3 4 5 →